Acute MI: Complete or Culprit-Only PCI in Older Patients with MI (FIRE trial)

Acute MI: Complete or Culprit-Only PCI in Older Patients with MI (FIRE trial)

Key points of the FIRE trial:

  • The study was a randomized trial of complete revascularization vs. culprit-only revascularization in older patients (≥75 years of age) with myocardial infarction and multi-vessel disease.
  • A total of 1445 patients were enrolled.
  • The primary outcome was a composite of death, myocardial infarction, stroke, or any revascularization at 1 year.
  • The key secondary outcome was a composite of cardiovascular death or myocardial infarction.
  • Safety was assessed as a composite of contrast-associated acute kidney injury, stroke, or bleeding.
  • The results showed that complete revascularization was associated with a lower risk of the primary outcome (15.7% vs. 21.0%, P=0.01) and the key secondary outcome (8.9% vs. 13.5%, P=0.01).
  • There was no difference in safety between the two groups.

In conclusion, the study found that complete revascularization is beneficial in older patients with myocardial infarction and multivessel disease. It is associated with a lower risk of death, myocardial infarction, stroke, and any revascularization at 1 year.

Here are some additional details from the study:

  • The median age of the patients was 80 years.
  • About 36% of the patients were women.
  • About 35% of the patients were admitted for ST-segment elevation myocardial infarction.
  • The safety outcome did not appear to differ between the groups, but the study was not powered to detect differences in safety.

The study findings support the use of complete revascularization in older patients with myocardial infarction and multivessel disease. However, it is important to note that the study was conducted in a single center and the results may not be generalizable to all patients. Further research is needed to confirm the findings of this study.


Link to the article: DOI: 10.1056/NEJMoa2300468

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(35)

REDUCE-AMI Trial: Diminishing Role of Beta-Blockers in ACS with preserved LVEF

REDUCE-AMI Trial: Diminishing Role of Beta-Blockers in ACS with preserved LVEF

1. The REDUCE-AMI trial showed no significant benefit of beta-blockers in reducing all-cause mortality or future myocardial infarction in patients with acute myocardial infarction and preserved left v...

24 Juni 20244min

Improving Left Ventricular Ejection Fraction in Heart Failure Patients: Insights from the HF-OPT Study

Improving Left Ventricular Ejection Fraction in Heart Failure Patients: Insights from the HF-OPT Study

The HF-OPT study investigated the improvement of left ventricular ejection fraction (LVEF) beyond 90 days in patients with newly diagnosed heart failure with reduced ejection fraction (HFrEF). In this...

22 Juni 20245min

AI in Cardiovascular Medicine: JACC Review

AI in Cardiovascular Medicine: JACC Review

Overview: This review discusses the use and future directions of AI in cardiology, focusing on areas like electrocardiography, telemetry and wearables, echocardiography, CMR, nuclear cardiology, CT, e...

21 Juni 20246min

2024 ACC Peripheral Artery Disease (PAD) Guidelines

2024 ACC Peripheral Artery Disease (PAD) Guidelines

Collaborative vascular care is emphasized to address health disparities, gaps in medical therapy, structured exercise, and good foot care along with appropriate revascularization to prevent limb loss....

31 Maj 20246min

2024 ACC/AHA Guidelines on Hypertrophic Cardiomyopathy

2024 ACC/AHA Guidelines on Hypertrophic Cardiomyopathy

2024 HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise Mavacamten: Class 1 recommendation for symptomatic obstructive HCM. Exercise: Now allows for "vigorous" activity; competitive lev...

21 Maj 20249min

DOACs: When direct oral anticoagulants should not be used?

DOACs: When direct oral anticoagulants should not be used?

Key Points: Positive Aspects of DOACs: DOACs are acknowledged for their convenience, efficacy, and safety in conditions like atrial fibrillation (AF) and venous thromboembolism (VTE). The review sup...

29 Jan 20244min

Cath: NPO vs Eating before Heart Cath

Cath: NPO vs Eating before Heart Cath

Background: Traditional practice requires fasting before cardiac catheterization, but there's no evidence to support it. Objective: This study compared a heart-healthy pre-procedure diet with fasting ...

26 Jan 20243min

Stable CAD and Angina: PCI without medical therapy as first treatment (ORBITA-2)

Stable CAD and Angina: PCI without medical therapy as first treatment (ORBITA-2)

Key Points In patients not taking antianginal meds, PCI alleviated some—but not all—symptoms Background: Percutaneous coronary intervention (PCI) is commonly used to alleviate stable angina symptom...

22 Jan 20243min

Populärt inom Hälsa

somna-med-henrik
rss-bara-en-till-om-missbruk-medberoende-2
rss-vuxna-pa-latsas
bullfika
sexnoveller-deluxe
inga-beiga-morsor
johannes-hansen-podcast
not-fanny-anymore
angestpodden
rss-viktmedicinpodden
sa-in-i-sjalen
tyngre-traningssnack
hacka-livet
rss-autismandan
sova-med-dan-horning
rss-angra-inget-3
rss-hos-psykologen
rss-basta-livet
rss-traningsklubben
psykologsnack